Table 3.
Laboratory parameter | Normal values |
Possible alterations in pregnancy with COVID‐19 | Potential prognostic markers | Levels reported in severe COVID‐19 outside pregnancya | |||
---|---|---|---|---|---|---|---|
Third trimester of pregnancy | Non‐ pregnant women | ||||||
PT | 8.5–11.0 seconds | 16.0 seconds |
|
Yes | 3 s extension >6 in 47.6% of non‐survivors with DIC compared to 3 in survivors |
||
APTT | 25.5–42.5 seconds | 27.0–37.0 seconds |
|
Yes | 5 s extension | ||
D‐dimer | 0.16–1.7 μg/mL |
|
Yes (severe disease and in hospital mortality Cut off: 2.0 μg/mL) |
2.12 in non survivors Vs 0.61 in survivors >3 in 86% non‐survivors with DIC |
|||
Platelet count Mean (range) |
Third trimester | Delivery | PP |
|
Yes Thrombocytopenia (severe disease + mortality) |
<100 in 33% of non‐survivors <50 in 24% non‐survivors with DIC |
|
225 (57–505) × 109/L | 217 (63–552) × 109/L | 264 (91–575) × 109/L | 273 (111–999) × 109/L | ||||
Fib | 2.48–5.06 g/L | 2.5–4.0 g/L |
|
Yes | 5.16 in non survivors vs 4.5 in survivors (non signifcant difference) <1 in 29% non‐survivors with DIC |
||
FDPs | <15 μg/mL | 3.09 ± 1.96 μg/mL |
|
7.6 in non survivors vs 4.0 in survivors |
Note
Please note this table is a guide. Age and ethnic variations exist and need to be considered. References:30., 34., 39., 40., 43., 89..
Abbreviations: APTT, activated partial thromboplastin time; DIC, disseminated intravascular coagulopathy; FDPs, fibrin degradation products; Fib, fibrinogen; PP, post partum; PT, prothrombin time; VTE, venous thromboembolism.
Reference:30; 71% of non‐survivors developed DIC (ISTH DIC score of ≥5) vs 0.6% of survivors.